Literature DB >> 2702444

Cardia carcinoma considered as a distinct clinical entity.

B Husemann1.   

Abstract

From 1 January 1969 until 31 December 1985, gastric resections were performed in 937 patients with carcinoma of the stomach and 422 patients with carcinoma of the cardia. During this period, the general frequency of cardia carcinoma increased continuously from 6.6 per cent (1969-71) to 37.5 per cent (1984-85) and a corresponding decrease of carcinomas in other sites was observed. Early carcinomas (pT1) of the oesophageal margin (n = 10, 2.4 per cent) were diagnosed less often than early carcinomas in other sites (n = 177, 18.9 per cent). Whereas 51.4 per cent of all resected carcinomas of the stomach showed no lymph node metastases (pN0), only 14.1 per cent of cardia carcinomas belonged to this category. With respect to operative treatment, Laurén's classification which defines the required margin of clearance according to diffuse type (frequency in cardia carcinoma 43 per cent, in other stomach sites 51 per cent), is of great significance. We believe that extensive oesophageal resection is necessary for patients with such difficult tumours. The pattern of metastasis in cardia carcinoma is similar to that of cancer in other stomach sites, the preferred area is the regional lymph nodes on the lesser curve (83 per cent). Histological classification and metastasis pattern show that cardia carcinoma is a type of carcinoma of the stomach which must be treated according to the criteria of stomach cancer surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2702444     DOI: 10.1002/bjs.1800760210

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  24 in total

1.  Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction.

Authors:  L Bonavina; S Ferrero; V Midolo; R Buffa; B Cesana; A Peracchia
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

Review 2.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

Review 3.  Oesophageal cancer: on the threshold of hope.

Authors:  T N Walsh
Journal:  Ir J Med Sci       Date:  1995 Jul-Sep       Impact factor: 1.568

4.  Comparison of the clinicopathological characteristics and the survival outcomes between the Siewert type II/III adenocarcinomas.

Authors:  Wei-Han Zhang; Xin-Zu Chen; Kai Liu; Kumar Anil; Kun Yang; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Med Oncol       Date:  2014-07-15       Impact factor: 3.064

5.  Sentinel node mapping in adenocarcinoma of the esophagogastric junction.

Authors:  Tatsuo Matsuda; Hiroya Takeuchi; Shinichi Tsuwano; Tadaki Nakahara; Makio Mukai; Yuko Kitagawa
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

6.  Lymph node metastasis in gastric cardiac adenocarcinoma in male patients.

Authors:  Gang Ren; Ying-Wei Chen; Rong Cai; Wen-Jie Zhang; Xiang-Ru Wu; Ye-Ning Jin
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

7.  Radical surgery for gastric cancer in Singapore.

Authors:  T K Ti
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Clinicopathologic analysis of esophageal and cardiac cancers and survey of molecular expression on tissue arrays in Chaoshan littoral of China.

Authors:  Min Su; Xiao-Yun Li; Dong-Ping Tian; Ming-Yao Wu; Xian-Ying Wu; Shan-Ming Lu; Hai-Hua Huang; De-Rui Li; Zhi-Chao Zheng; Xiao-Hu Xu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

9.  Optimal surgical management for esophagogastric junction carcinoma.

Authors:  Tatsuo Matsuda; Hiroya Takeuchi; Shinichi Tsuwano; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Yoshiro Saikawa; Tai Omori; Yuko Kitagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-26

10.  Prognostic value of Goseki histological classification in adenocarcinoma of the cardia.

Authors:  M G Fontana; M La Pinta; D Moneghini; V Villanacci; F Donato; G Rindi; S Paparini; C Baronchelli; G Bertoli; P Alquati
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.